Home
/

Sodium: the electrolyte your kidneys guard within a narrow band

REVIEWED BY
Bill Maish, MD
Clinical Content Consultant
Published
May 30, 2026
Last updated
May 30, 2026
Key takeaway:

Sodium is the body's primary extracellular electrolyte, regulated within a narrow range of 135–145 mEq/L by the kidneys, adrenal glands, and brain. Values outside this range impair nerve conduction, muscle contraction, and fluid balance within hours. Athletes can lose 1–2 grams of sodium per liter of sweat, making electrolyte replacement critical during prolonged training or heat exposure.

Read more →
Table of contents
```html

Sodium, defined in plain electrolyte terms

Serum sodium measures the concentration of sodium ions in your blood, expressed in milliequivalents per liter (mEq/L). Sodium is the body's primary extracellular electrolyte — it lives mostly outside your cells, helping maintain fluid balance, nerve conduction, and muscle contraction. The kidneys, adrenal glands, and brain work constantly to keep sodium within a narrow range, typically around 135–145 mEq/L, though reference intervals vary slightly by laboratory. That tight regulation matters: too little sodium and cells swell with excess water; too much and they shrink from dehydration — both extremes can impair brain, heart, and muscle function within hours.

How serum sodium reflects fluid and hydration balance

Think of sodium as your body's battery fluid. It keeps electrical signals firing across nerve cells and muscles, including the heart. When you move, think, or sweat, sodium moves too — flowing in and out of cells to generate the voltage shifts that make life possible.

Water follows sodium like a magnet, which is why serum sodium tells you as much about hydration and kidney function as about anything else. When sodium drifts high, it often means the body is losing more water than salt — through dehydration or diuretics. When sodium drops, the body may be retaining excess water or losing sodium through sweat, illness, or certain medications. These shifts are governed by antidiuretic hormone (ADH) and the renin-angiotensin-aldosterone system (RAAS), which together respond within hours to days to changes in fluid status.

Serum sodium does not directly reflect dietary salt intake — healthy kidneys regulate serum concentration regardless of how much salt you consume.

Sodium balance is also a marker of systemic regulation — the ability of your kidneys, hormones, and cardiovascular system to maintain internal order under stress. In longevity research, maintaining stable sodium within range is associated with fewer cardiovascular events, likely because proper electrolyte balance stabilizes blood pressure and hydration dynamics over time.

Reading your sodium number in context

Normal range

The reference range — 135–145 mEq/L — is narrow for a reason; the brain and heart depend on it. Exact cutoffs vary slightly by laboratory, so results should always be interpreted against the reference interval on your report. Context also matters: endurance athletes, people in hot climates, and those on low-carb or diuretic regimens may sit at different points within the range depending on their hydration and activity status at the time of the draw.

High serum sodium (hypernatremia)

Hypernatremia — sodium above 145 mEq/L — usually reflects water loss outpacing sodium loss. Common causes include dehydration from heat, exercise, fever, or insufficient fluid intake. Less commonly, it results from hormonal imbalances such as low ADH (antidiuretic hormone). Symptoms include thirst, fatigue, and confusion; in severe cases, muscle twitching or seizures can occur. Clinical management of persistent hypernatremia is directed by the underlying cause, and persistent elevation suggests kidney or adrenal dysfunction warranting medical follow-up.

Low serum sodium (hyponatremia)

Hyponatremia — sodium below 135 mEq/L — occurs when the body retains too much water or loses too much sodium. It is common in endurance athletes who replace fluid without replacing electrolytes, and in conditions such as adrenal insufficiency, heart failure, or use of certain medications including SSRIs and diuretics. Symptoms range from mild fatigue and nausea to confusion, headache, and in extreme cases, cerebral edema. Persistent hypernatremia or hyponatremia warrants evaluation of the underlying mechanism, and rapid correction can be dangerous.

Factors that move sodium up or down between draws

Because sodium is tightly regulated by ADH and the RAAS axis, most day-to-day variation in a serum result reflects acute changes in fluid status, medications, or physiological stress rather than long-term dietary patterns.

  • Medications: Diuretics (thiazide and loop) are among the most common causes of low serum sodium, promoting renal sodium excretion. SSRIs can trigger syndrome of inappropriate ADH secretion (SIADH), causing dilutional hyponatremia. Corticosteroids and certain blood pressure medications can raise sodium by promoting retention.
  • Kidney function: The kidneys are the primary regulators of sodium excretion. Impaired renal function — from chronic kidney disease or acute injury — disrupts this regulation and can push sodium in either direction depending on the mechanism.
  • Exercise-associated hyponatremia: Prolonged endurance exercise, particularly when large volumes of plain water are consumed without electrolyte replacement, can dilute serum sodium significantly. Athletes training in heat can lose 1–2 grams of sodium per liter of sweat, and replacing that volume with water alone lowers serum concentration.
  • ADH-affecting conditions: Any condition that stimulates inappropriate ADH release — including heart failure, liver cirrhosis, pulmonary disease, and certain cancers — can cause dilutional hyponatremia by promoting water retention independent of sodium intake.
  • Adrenal function: Aldosterone, produced by the adrenal glands, directly governs renal sodium reabsorption. Adrenal insufficiency (low aldosterone) leads to sodium wasting; excess aldosterone (primary hyperaldosteronism) causes sodium retention.
  • Stress hormones: Cortisol and aldosterone both influence sodium retention. Chronic physiological stress can alter fluid balance and affect where sodium sits within or outside the reference range.
  • Hydration status at draw: Dehydration at the time of the blood draw concentrates all serum values, including sodium. Consistent pre-draw conditions — same time of morning, similar hydration — improve the comparability of serial results.

The electrolyte panel that reads sodium in context

Sodium is rarely interpretable in isolation. The following biomarkers, measured alongside sodium on a basic or comprehensive metabolic panel, provide the context needed to distinguish between causes of dysregulation:

  • Potassium — sodium and potassium are regulated in tandem by the renal aldosterone axis; a concurrent low potassium with low sodium points toward diuretic use or adrenal dysfunction rather than simple dehydration.
  • Chloride — chloride moves with sodium in most conditions; a sodium-chloride gap can indicate metabolic alkalosis or non-gap acidosis that changes the interpretation.
  • Creatinine — rising creatinine alongside rising sodium distinguishes pre-renal dehydration (both rise) from SIADH (sodium falls while creatinine is stable), guiding evaluation.
  • Blood urea nitrogen (BUN) — the BUN/creatinine ratio contextualizes whether sodium dysregulation reflects volume depletion vs. inappropriate ADH secretion.
  • Carbon dioxide (CO2) — bicarbonate/CO2 completes the basic metabolic panel acid-base picture; alkalosis or acidosis can accompany sodium shifts from diuretics and renal tubular conditions.

When a sodium recheck actually adds information

Sodium is tightly regulated by ADH and the RAAS axis and responds within hours to days to changes in fluid status or medication, making it a snapshot of acute conditions rather than a tractable long-term trend marker. A single out-of-range result in an otherwise healthy person often reflects transient dehydration or pre-draw conditions rather than a persistent problem.

For individuals with stable health and no relevant comorbidities, annual testing as part of a routine metabolic panel is sufficient. More frequent retesting is clinically indicated in the following situations:

  • Current use of diuretics, SSRIs, or other medications known to affect sodium
  • Diagnosed kidney disease, heart failure, or liver disease
  • Following any acute episode of hyponatremia or hypernatremia
  • Monitoring during or after a significant change in fluid intake, exercise load, or clinical status

For meaningful comparison across draws, consistent pre-draw conditions matter — same lab, same time of morning, and similar hydration status, since dehydration at the time of draw concentrates serum values and can shift a result within or outside the reference range.

When a sodium result warrants a clinician's review

Sodium testing is one of the simplest yet most essential snapshots of whole-body regulation. It reveals how kidneys, hormones, and hydration work in concert — and tracking it alongside the companion electrolytes above provides early insight into dehydration risk, medication effects, and metabolic stress, often before symptoms arise.

A result outside the 135–145 mEq/L range — particularly if accompanied by symptoms, a concurrent abnormality in potassium, creatinine, or BUN, or a rapid change from a prior value — warrants clinical evaluation. Rapid shifts in sodium in either direction carry neurological risk and should not be managed without medical oversight.

Superpower's comprehensive biomarker panel tracks sodium alongside potassium, chloride, and kidney function markers to map electrolyte health over time. Understanding how hydration, medications, and physiological stress affect these levels is central to the Superpower approach to proactive health. Visit superpower.com to learn more.

```

FAQs

A serum sodium test measures the concentration of sodium ions in the blood, reported in milliequivalents per liter (mEq/L). Sodium is the primary extracellular electrolyte and plays a central role in regulating fluid balance, blood pressure, and nerve and muscle function. It is a standard component of both the basic and comprehensive metabolic panel.
Sodium drives osmosis: water moves across cell membranes toward areas of higher sodium concentration. The kidneys, in response to aldosterone and antidiuretic hormone (ADH), adjust how much sodium is excreted or retained to maintain serum concentration and blood volume. This regulatory system controls hydration status and blood pressure simultaneously.
The reference range for serum sodium in adults is 136 to 145 mEq/L. Values below 136 mEq/L indicate hyponatremia; values above 145 mEq/L indicate hypernatremia. Both conditions can affect neurological and cardiovascular function. Reference ranges may vary slightly between laboratories, so results should be reviewed with your clinician in context.
Hyponatremia is most commonly associated with excess fluid retention, kidney dysfunction, heart failure, liver disease, adrenal insufficiency, or diuretic use. Overhydration with plain water during prolonged endurance exercise is a recognized acute cause. Each mechanism affects sodium balance differently and requires specific clinical evaluation to identify the correct underlying driver.
Mild sodium imbalances are often asymptomatic and detected only through routine testing. More significant deviations can be associated with nausea, headache, confusion, muscle weakness, or fatigue. Because these symptoms are non-specific, a blood test is essential for determining whether sodium dysregulation is a contributing factor versus another cause.
In healthy individuals, the kidneys efficiently regulate serum sodium regardless of dietary intake, so eating more or less salt does not typically shift serum values measurably. However, high-sodium diets are associated with increased blood pressure and fluid retention in sodium-sensitive individuals. Serum sodium is more a marker of fluid regulation than a direct reflection of dietary salt consumption.

References

  1. Hoorn, E. J., & Zietse, R. (2017). Diagnosis and Treatment of Hyponatremia: Compilation of the Guidelines. Journal of the American Society of Nephrology, 28(5), 1340-1349. https://doi.org/10.1681/ASN.2016101139
  2. Spasovski, G., Vanholder, R., Allolio, B., Annane, D., Ball, S., Bichet, D., Decaux, G., Fenske, W., Hoorn, E. J., Ichai, C., Joannidis, M., Soupart, A., Zietse, R., Haller, M., van der Veer, S., Van Biesen, W., Nagler, E., & Hyponatraemia Guideline Development Group (2014). Clinical practice guideline on diagnosis and treatment of hyponatraemia. Nephrology, dialysis, transplantation, 29 Suppl 2, i1-i39. https://doi.org/10.1093/ndt/gfu040
  3. Klingert, M., Nikolaidis, P. T., Weiss, K., Thuany, M., Chlíbková, D., & Knechtle, B. (2022). Exercise-Associated Hyponatremia in Marathon Runners. Journal of clinical medicine, 11(22). https://doi.org/10.3390/jcm11226775
  4. Nagashima, T., Hayakawa, T., Akimoto, H., Minagawa, K., Takahashi, Y., & Asai, S. (2022). Identifying Antidepressants Less Likely to Cause Hyponatremia: Triangulation of Retrospective Cohort, Disproportionality, and Pharmacodynamic Studies. Clinical pharmacology and therapeutics, 111(6), 1258-1267. https://doi.org/10.1002/cpt.2573
  5. Nagler, E. V., Vanmassenhove, J., van der Veer, S. N., Nistor, I., Van Biesen, W., Webster, A. C., & Vanholder, R. (2014). Diagnosis and treatment of hyponatremia: a systematic review of clinical practice guidelines and consensus statements. BMC medicine, 12, 1. https://doi.org/10.1186/s12916-014-0231-1

Built by the world’s top doctors and scientists

Dr Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Board-certified longevity physician. Previously product leader at Virta Health & CMO at Modern Age. Featured in  WSJ, Forbes, and Fortune.

Learn more

Dr Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Leads the largest integrative medical clinic in North America. A pioneer in integrative oncology.

Learn more

Dr Robert Lufkin

UCLA Medical Professor, NYT Bestselling Author

A leading voice on metabolic health and longevity as shown in The Today Show, USA Today and FOX.

Learn more

Dr Abe Malkin

Founder & Medical Director of Concierge MD

Leads a nationwide medical practice, and Drip Hydration, a mobile IV therapeutics company

Learn more
Membership slide 1
Membership slide 1
Membership slide 2
Membership slide 3
1 / 3

Your membership starts here

Annual 100+ biomarker panel

Data dashboard and digital twin

Upload past labs and connect wearables

Personalized health protocol

24/7 care team access

AI companion for all health questions

Marketplace with additional solutions

$199

/year*

Billed annually

HSA/ FSA eligible
Cancel anytime
Results in a week

* Pricing may vary for members in New York and New Jersey